| # | Drug | Count |
|---|---|---|
| 0 | VINCRISTINE SULFATE | 19 |
| 1 | CYTARABINE | 16 |
| 2 | METHOTREXATE SODIUM | 15 |
| 3 | METHOTREXATE | 14 |
| 4 | PEGASPARGASE | 13 |
| 5 | DEXAMETHASONE | 12 |
| 6 | DEXAMETHASONE 1.5 MG | 12 |
| 7 | PREDNISONE | 10 |
| 8 | CYCLOPHOSPHAMIDE | 9 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SMOFLIPID | 2 | 0.0023 |
| 1 | NIZATIDINE | 2 | 0.0013 |
| 2 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 3 | PEGASPARGASE | 13 | 0.0011 |
| 4 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| 5 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 6 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 7 | VINCRISTINE SULFATE | 19 | 0.0006 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| 9 | ANIDULAFUNGIN | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 32 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 21 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 4 | Asparagine-specific Enzyme [EPC] | 13 |
| 5 | Alkylating Drug [EPC] | 9 |
| 6 | Osmotic Laxative [EPC] | 9 |
| 7 | Vitamin C [EPC] | 8 |
| 8 | Platinum-based Drug [EPC] | 7 |
| 9 | Proton Pump Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 13 | 0.0010 |
| 1 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 2 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 3 | Antiseptic [EPC] | 2 | 0.0005 |
| 4 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 6 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 7 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 8 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 21 | 0.0001 |